IDENTIFICATION OF RESPONDER AND DISEASE ACTIVITY THRESHOLDS FOR THE PSORIATIC ARTHRITIS IMPACT OF DISEASE-12 (PSAID-12) QUESTIONNAIRE USING POOLED DATA FROM TWO PHASE 3 TRIALS OF BIMEKIZUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS

被引：1
|
作者：
Gossec, L. [1 ,2 ]
Coates, L. [3 ]
Orbai, A. M. [4 ]
De Wit, M. [5 ]
Pelligra, C. [6 ]
Lambert, J. [7 ]
Ciaravino, V. [7 ]
Ink, B. [8 ]
Taieb, V. [7 ]
Gladman, D. D. [9 ]
机构：
[1] Sorbonne Univ, Paris, France
[2] Hop La Pitie Salpetriere, AP HP, Paris, France
[3] Univ Oxford, Nuffield Dept Orthopaed, Rheumatol & Musculoskeletal Sci, Oxford, England
[4] Johns Hopkins Univ, Div Rheumatol, Sch Med, Baltimore, MD USA
[5] Stichting Tools, Amsterdam, Netherlands
[6] Evidera, Medellin, Colombia
[7] UCB Pharma, Colombes, France
[8] UCB Pharma, Slough, Berks, England
[9] Univ Toronto, Schroeder Arthrit Inst, Krembil Res Inst, Toronto Western Hosp, Toronto, ON, Canada
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Psoriatic arthritis; Clinical trials; Patient reported outcomes; OUTCOME MEASURE; VALIDATION;
D O I：
10.1136/annrheumdis-2023-eular.1980
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS0590-HP
引用
收藏
页码：565 / 566
页数：2
相关论文
共 50 条
  • [21] Patient global assessment in psoriatic arthritis - what does it mean? An analysis of 223 patients from the Psoriatic arthritis impact of disease (PsAID) study
    Talli, Sandra
    Etcheto, Adrien
    Fautrel, Bruno
    Balanescu, Andra
    Braun, Jurgen
    Canete, Juan D.
    de Vlam, Kurt
    de Wit, Maarten
    Heiberg, Turid
    Helliwell, Philip
    Kalyoncu, Umut
    Kiltz, Uta
    Maccarone, Mara
    Niedermayer, Dora
    Otsa, Kati
    Scrivo, Rossana
    Smolen, Josef S.
    Stamm, Tanja
    Veale, Douglas J.
    Kvien, Tore K.
    Gossec, Laure
    JOINT BONE SPINE, 2016, 83 (03) : 335 - 340
  • [22] Effect of Deucravacitinib on the Psoriatic Arthritis Impact of Disease Questionnaires 12 and 9: Analysis of a Phase 2 Study of Active Psoriatic Arthritis
    Gossec, Laure
    Coates, Laura
    Ogdie--Beatty, Alexis
    Mease, Philip
    Lehman, Tom
    Nowak, Miroslawa
    Wei, Lan
    Ye, June
    Choi, Jiyoon
    Zhuo, Joe
    Becker, Brandon
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 1520 - 1522
  • [23] Construct validity, reliability, and threshold value for treatment goals of the Thai version of the 12-item Psoriatic Arthritis Impact of Disease Questionnaire for patients with psoriatic arthritis
    Chiowchanwisawakit, Praveena
    Orawongpaisarn, Annop
    Katchamart, Wanruchada
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2024, 27 (04)
  • [24] Effect of bimekizumab on symptoms and impact of disease in patients with psoriatic arthritis over 3 years: results from BE ACTIVE
    Mease, Philip J.
    Asahina, Akihiko
    Gladman, Dafna D.
    Tanaka, Yoshiya
    Tillett, William
    Ink, Barbara
    Assudani, Deepak
    de la Loge, Christine
    Coarse, Jason
    Eells, Jason
    Gossec, Laure
    RHEUMATOLOGY, 2023, 62 (02) : 617 - 628
  • [25] Effect of bimekizumab on patient-reported disease impact in patients with psoriatic arthritis: 1-year results from two phase 3 studies
    Gossec, Laure
    Orbai, Ana-Maria
    de Wit, Maarten
    Coates, Laura C.
    Ogdie, Alexis
    Ink, Barbara
    Coarse, Jason
    Lambert, Jeremy
    Taieb, Vanessa
    Gladman, Dafna D.
    RHEUMATOLOGY, 2024,
  • [26] THE SONELOKIMAB NANOBODY® IN PATIENTS WITH PSORIATIC DISEASE: WEEK 12 MULTIDOMAIN OUTCOMES FROM THE PHASE 2 ARGO PSORIATIC ARTHRITIS TRIAL
    Merola, Joseph F.
    Mcinnes, Iain B.
    Coates, Laura C.
    Mease, Philip J.
    Gottlieb, Alice B.
    Warren, Richard B.
    Eder, Lihi
    Attar, Naomi
    Godwood, Alex
    Cullen, Eva
    Reich, Kristian
    Ritchlin, Christopher T.
    ACTA DERMATO-VENEREOLOGICA, 2024, 104
  • [27] Association of Nail Psoriasis With Disease Activity Measures and Impact in Psoriatic Arthritis: Data From the Corrona Psoriatic Arthritis/Spondyloarthritis Registry
    Mease, Philip J.
    Liu, Mei
    Rebello, Sabrina
    McLean, Robert R.
    Dube, Blessing
    Glynn, Meghan
    Hur, Peter
    Ogdie, Alexis
    JOURNAL OF RHEUMATOLOGY, 2021, 48 (04) : 520 - 526
  • [28] Comparison of disease activity index for psoriatic arthritis (DAPSA) and minimal disease activity (MDA) targets for patients with psoriatic arthritis: A post hoc analysis of data from phase 3 tofacitinib studies
    Schneeberger, Emilce E.
    Citera, Gustavo
    Nash, Peter
    Smolen, Josef S.
    Mease, Philip J.
    Soriano, Enrique R.
    Helling, Claudia
    Szumski, Annette E.
    Mundayat, Rajiv
    de Leon, Dario Ponce
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2023, 58
  • [29] Impact of Skin Involvement on Disease Burden Among Patients with Psoriatic Arthritis: Data from the Corrona Psoriatic Arthritis/Spondyloarthritis Registry
    Mease, Philip
    McLean, Robert
    Blachley, Taylor
    Anatale-Tardiff, Laura
    Saffore, Christopher
    Lovan, Charlie
    Ogdie, Alexis
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [30] PROBABILITY AND IMPACT OF ACHIEVING LOW DISEASE ACTIVITY OR REMISSION IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH APREMILAST: POOLED ANALYSIS OF THE PALACE 1-3 PHASE 3 TRIALS
    McInnes, I.
    Mease, P. J.
    Behrens, F.
    Orbai, A. -M.
    Brunori, M.
    Teng, L.
    Guerette, B.
    Smolen, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1588 - 1589
12345